---
title: "Scientific Consultant for Medicines Discovery Catapult"
ocid: "ocds-h6vhtk-05eb03"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05eb03"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-05eb03.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-05eb03.json"
source: "Find A Tender Service"
current_stage: "Tender"
buyer: "MEDICINES DISCOVERY CATAPULT LIMITED"
published: "2025-11-28"
---

# Scientific Consultant for Medicines Discovery Catapult

Buyer: MEDICINES DISCOVERY CATAPULT LIMITED  
Current stage: Tender  
OCID: ocds-h6vhtk-05eb03

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05eb03)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-05eb03.json)

## Summary

The Medicines Discovery Catapult Limited seeks a Scientific Consultant to aid its efforts in drug discovery innovation, focusing on neuroscience and other high-risk patient needs. As the contracting authority, based in Macclesfield, UK, the organisation is looking to expand and delve into areas such as neurodegenerative diseases and CNS drug delivery. This procurement process, initiated under an open competition below the threshold, is currently at the tender stage, with submissions due by 19th December 2025. The contract, valued at £75,000, is scheduled to commence on 1st February 2026, lasting until 31st August 2026, with possible renewals. Industry classification centers around research and development consultancy services.

This tender presents substantial growth opportunities for businesses proficient in scientific consulting, particularly those with expertise in neuroscience and infection. Firms adept at synthesising scientific data, technical writing, and offering strategic insights will find themselves well-positioned to meet the requirements. Access to databases like PubMed or Europe PMC, along with capabilities in using AI for data analysis, is crucial for success. Small and medium enterprises specialising in life sciences could greatly benefit, leveraging this project to collaborate across academia, biotech, and global pharmaceutical sectors.

## Notice

Medicines Discovery Catapult (MDC) is an independent, not-for-profit innovation centre for drug discovery and part of the Catapult Network established by Innovate UK. MDC's vision is to reshape drug discovery for patient benefit by transforming great UK science into better treatments through partnership. It supports drug discovery innovators by making world-class expertise, facilities, complex technologies, and advanced analytics accessible to enable successful medicines discovery. MDC develops pioneering, impactful R&D collaborations across biotech, academia, technology companies, charities, and global pharma. It brings these communities together in active, focused national programmes that target high-risk areas of patient need. This requirement originates from the Partnership Team at Medicines Discovery Catapult (MDC), which includes national programmes across neuroscience and infection, virtual R&D, and complex medicine. The team plays a central role in enabling and accelerating UK drug discovery by identifying unmet needs, supporting ecosystem coordination, and helping to navigate the scientific and translational complexities of areas such as diseases of the brain. To fulfil its role effectively, the team must remain consistently informed about recent scientific developments, innovation opportunities, and areas of commercial promise. This enables MDC to identify and shape collaborative initiatives, support investment cases, and build strategies aligned to evolving national and global health priorities. The current emphasis has been on neuroscience, particularly neurodegenerative diseases, mental health, and drug discovery and delivery. Previous work has included: * A landscape mapping exercise to inform the strategy for the Dementia Goals Programme, providing a foundational view of the UK's capabilities, gaps, and opportunities; * Exploration of emerging scientific trends and innovation gaps within mental health, supporting the work of the Psychiatry Consortium; * Early-stage analysis on cross-cutting opportunities within complex medicine. Building on this initial work, MDC now seeks to expand the scope and focus of the landscape activity to include: * Deeper insights into priority areas aligned to the Partnership Team's strategic objectives; * A clearer understanding of challenges such as blood-brain barrier (BBB) penetration and the development of novel Central Nervous System drug modalities; * Identification of translational and commercial opportunities across neuroscience and beyond (e.g., infectious diseases). MDC requires a consultant to: * Provide ongoing scientific and strategic intelligence relevant to current and future areas of focus and interest such as neuroscience, infection, CNS drug delivery, etc. * Identify translational and commercial opportunities through horizon scanning and landscape analysis in defined scientific areas. * Support development of investment cases and programme design by synthesising internal and external data sources. * Produce materials including presentations, written briefs, dashboards, and updates for internal and external stakeholders. Deliverables would be specific for each project, but it is expected that they could include: * Monthly briefings summarising relevant scientific, policy, and/or commercial developments (oral or written). * At least one deep-dive landscape output (e.g., dashboard, short report or slide deck) per quarter, focused on agreed priority themes (e.g., BBB, emerging modalities, patient stratification). * Ad hoc input to internal programme development and stakeholder materials (e.g., funder presentations, project design). The supplier must have a proven track record of delivering high quality technical writing, with strong communication skills. A minimum of 5 years' experience in technical or scientific writing, with demonstrable experience in life sciences. Access to proprietary databases to access the relevant datasets useful for the specific projects (including OpenAlex, Europe PMC, PubMed, CrossRef, Dimensions, Lens.org (patents), ClinicalTrials.gov, WHO ICTRP, NICE Evidence). Expertise in the use of AI and language models to automate and classify data retrieval and apply thematic analyses Proven ability to synthesise scientific and commercial insights for strategic use. Previously work in areas relevant to MDC strategic mission.

### Lot Information

Lot 1

Renewal: Medicines Discovery Catapult will have the option to extend the contract for a further two 12 month periods, dependent on satisfactory performance and work required.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/078062-2025 |
| Notice type | UK4 - Tender Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Open |
| Procurement method details | Below threshold - open competition |
| Tender suitability | SME |
| Awardee scale | Not specified |
| All stages | Tender |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Nov 2025 |
| Submission deadline | 19 Dec 2025 |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 1 Feb 2026 - 31 Aug 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £75,000 |
| Lots value | £75,000 |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Active |
| Lots status | Active |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | MEDICINES DISCOVERY CATAPULT LIMITED |
| Locality | MACCLESFIELD |
| Post town | Stockport |
| Postcode | SK10 4ZF |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD6 Cheshire |
| ITL 3 | TLD62 Cheshire East |
| Local authority | Cheshire East |
| Electoral ward | Chelford |
| Westminster constituency | Tatton |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 73 - Research and development services and related consultancy services

### Codes

- 73000000 - Research and development services and related consultancy services

## Release History

- 28 Nov 2025 at 12:36 - Tender - UK4 - Tender Notice - https://www.find-tender.service.gov.uk/Notice/078062-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/078062-2025
  28th November 2025 - Tender notice on Find a Tender

## Notice URLs

- https://procontract.due-north.com/Advert?advertId=a2f7173e-54cc-f011-813a-005056b64545
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-05eb03. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-05eb03.json.